SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Tradegate System der Deutsche Börse AG (60%)
Börse Tradegate System der Deutsche Börse AG (60%)
Symbol JNJ
EUR
  • Johnson & Johnson
    Börse Börse Frankfurt
    ISIN US4781601046
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse Stuttgart
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse München
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse Berlin
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Xetra Frankfurt
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Gettex System der Börse München
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Quotrix System der Börse Düsseldorf
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Börse Düsseldorf
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Börse Hamburg
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse SGO
    USD
  • Johnson & Johnson
    Börse BUE
    USD
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
  • Johnson & Johnson
    Börse SSE
Symbol JNJ
Währung EUR
Börse Tradegate System der Deutsche Börse AG (60%) Zeitzone: Europe/Berlin
Marktkapitalisierung 99.567.000.000
Mitarbeiter 141.700

Analystenmeinungen

Übersicht

Aktionärsstruktur der Johnson & Johnson

2.654 News & Informationen zur Johnson & Johnson Aktie

  • Global Industry Analysts Predicts The World Human Reproductive Technologies Market To Reach $28 Billion By 2026
    thestreet.com

    Global Industry Analysts Predicts The World Human Reproductive Technologies Market To Reach $28 Billion By 2026

    SAN FRANCISCO, Sept. 1, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • Johnson & Johnson : Janssen Announces U.S. FDA Approval of INVEGA HAFYERA™ (6-month paliperidone palmitate), First and Only Twice-Yearly...
    marketscreener.com

    Johnson & Johnson : Janssen Announces U.S. FDA Approval of INVEGA HAFYERA™ (6-month paliperidone palmitate), First and Only Twice-Yearly Treatment for Adults with Schizophrenia

    News Release

    Media contact:

    Kelsey Buckholtz +1-908-208-5428kbuckh1@its.jnj.com

    Kaitlin Meiser… | September 1, 2021

  • France first big EU nation to start widespread booster jabs
    abcnews.go.com

    France first big EU nation to start widespread booster jabs

    France has started administering booster shots of COVID-19 vaccine to people over 65 and those with underlying health conditions

  • A Harvard “As Humane as It Is Humbling”: Morning Prayers
    harvardmagazine.com

    A Harvard “As Humane as It Is Humbling”: Morning Prayers

    In Memorial Church, and at other opening-days exercises, President Bacow encourages the community to “excel in small moments.”

  • Johnson & Johnson wins FDA approval for long-acting schizophrenia med (NYSE:JNJ)
    seekingalpha.com

    Johnson & Johnson wins FDA approval for long-acting schizophrenia med (NYSE:JNJ)

    The Janssen Pharmaceutical Companies, a unit of Johnson & Johnson (JNJ) announced that the FDA approved its long-acting atypical antipsychotic INVEGA HAFYERA for…

  • Quotient Limited Announces Christian Albrich as Chief People Officer
    globenewswire.com

    Quotient Limited Announces Christian Albrich as Chief People Officer

    JERSEY, Channel Islands, Sept. 01, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the…

  • 9 Dreamy Hotels For A Late Summer Getaway In Spain’s Balearic Islands
    forbes.com

    9 Dreamy Hotels For A Late Summer Getaway In Spain’s Balearic Islands

    Despite the new restrictions on travel from the U.S. to Europe, Spain is expected to remain open to vaccinated American visitors.

  • You have the right to not vaccinate – but you don’t have the right to endanger other people: health minister
    businesstech.co.za

    You have the right to not vaccinate – but you don’t have the right to endanger other people: health minister

    South Africa may limit the use of public amenities to the people who have been vaccinated against Covid-19, the country’s health minister said.

  • How long do COVID-19 vaccines protect you for? Experts explain
    weforum.org

    How long do COVID-19 vaccines protect you for? Experts explain

    Some countries, such as Israel, are already rolling out a third booster shot to provide extra immunity to the most vulnerable members of their population.

  • Immigrants Slow To Get Covid-19 Vaccine As Impediments Block Their Access
    forbes.com

    Immigrants Slow To Get Covid-19 Vaccine As Impediments Block Their Access

    Non-citizens are lagging behind in vaccination rates in the U.S. More effort will need to be made to reach these individuals and persuade them to get their shots.

  • September EU Travel Restrictions: Covid-19 Vaccination, Testing And Quarantine Rules By Country
    forbes.com

    September EU Travel Restrictions: Covid-19 Vaccination, Testing And Quarantine Rules By Country

    The country-by-country guide to Europe's Covid-19 testing, vaccination and quarantine requirements is still in flux for September, particularly as the EU has taken the U.S. off its safe travel list.

  • The Worldwide DNA Vaccines Industry Should Reach $11.5 Billion By 2026
    thestreet.com

    The Worldwide DNA Vaccines Industry Should Reach $11.5 Billion By 2026

    DUBLIN, Sept. 1, 2021 /PRNewswire/ — The

  • Insights On The Medical Device Global Market To 2030 - By Category, Application, End-user And Region
    thestreet.com

    Insights On The Medical Device Global Market To 2030 – By Category, Application, End-user And Region

    DUBLIN, Aug. 31, 2021 /PRNewswire/ — The “Global Medical Device Market 2020-2030 by Category, Application, End User, and Region: Trend Forecast and Growth

  • Read McCann's tribute to former chairman-CEO Bob James, who has passed away
    adage.com

    Read McCann's tribute to former chairman-CEO Bob James, who has passed away

    Current Worldgroup chief Bill Kolb pens remembrance to employees.

  • Are Vaccines A Shot In The Arm For Retail Recovery?
    forbes.com

    Are Vaccines A Shot In The Arm For Retail Recovery?

    Covid vaccine mandates may be good for retail sales, new research shows. But there is nothing new about consumer fears that support a preference for stores with inoculated workers. Here’s how Covid is giving the common fears marketers prey upon new context, and how retailers can use it for good.

  • Two FDA Vaccine Officials to Step Down After Covid Clearances
    bloombergquint.com

    Two FDA Vaccine Officials to Step Down After Covid Clearances

    (Bloomberg) — Two key vaccine officials are preparing to step down from the U.S. Food and Drug Administration, which raced to clear Covid shots to fight the pandemic and is now considering President Joe Biden’s booster plan.

  • Two Senior FDA Officials Stepping Down Over Reported Disagreements With White House Over Booster Shots
    zerohedge.com

    Two Senior FDA Officials Stepping Down Over Reported Disagreements With White House Over Booster Shots

    ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero

  • AI startups claim to detect depression from speech, but the jury’s out on their accuracy
    venturebeat.com

    AI startups claim to detect depression from speech, but the jury’s out on their accuracy

    Startups including Ellipsis Health say they can diagnose depression from voice by using AI. Experts aren't so sure.

  • Krispy Kreme Doubles Free Doughnuts For Covid-19 Vaccination Card Holders
    rttnews.com

    Krispy Kreme Doubles Free Doughnuts For Covid-19 Vaccination Card Holders

    Krispy Kreme, the home of the Original Glazed Doughnut, has sweetened its offer of free doughnuts for Covid-19 Vaccination Card Holders for a week as an incentive booster to encourage more people to get vaccinated amid the recent spike in coronavirus infection rates across the U.

  • World Political Risk Rating System 2021
    prnewswire.com

  • South Africa to look into vaccinating children once most adults are covered
    businesstech.co.za

    South Africa to look into vaccinating children once most adults are covered

    Government is making every effort to reach population immunity and is investigating immunising children with the remaining vaccine stock once most adults are…

  • Johnson & Johnson's HIV vaccine fails mid-stage Africa study
    cnbc.com

    Johnson & Johnson's HIV vaccine fails mid-stage Africa study

    Johnson & Johnson said on Tuesday its experimental vaccine failed to provide sufficient protection against HIV in sub-Saharan Africa to young women.

  • Johnson & Johnson's HIV vaccine fails mid-stage Africa study
    livemint.com

    Johnson & Johnson's HIV vaccine fails mid-stage Africa study

    The results from the mid-stage study are the latest setback to efforts to develop a vaccine to prevent HIV or human immunodeficiency virus, which causes AIDS that had infected over 37 million people globally as of 2020

  • Johnson & Johnson halts clinical trial for HIV vaccine in Africa (NYSE:JNJ)
    seekingalpha.com

    Johnson & Johnson halts clinical trial for HIV vaccine in Africa (NYSE:JNJ)

    Having evaluated mid-stage data for its investigational HIV vaccine, Johnson & Johnson (JNJ) has decided to discontinue the Phase 2b HIV vaccine clinical trial known as the Imbokodo…

  • Johnson & Johnson: HIV Vaccine Candidate Fails To Provide Protection; To Discontinue Imbokodo Study
    markets.businessinsider.com

    Johnson & Johnson: HIV Vaccine Candidate Fails To Provide Protection; To Discontinue Imbokodo Study

    (RTTNews) – Johnson & Johnson (JNJ) said results from the primary analysis of a phase 2b vaccine clinical trial showed the investigational HIV vac…

  • Johnson & Johnson : and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan...
    marketscreener.com

    Johnson & Johnson : and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa

    NEW BRUNSWICK, N.J., Aug. 31, 2021 /PRNewswire/ — Johnson & Johnson , together with a consortium of global partners, today announced results from the primary analysis of a Phase 2b HIV… | August 31, 2021

  • EU says it has reached goal of vaccinating 70% of adults
    financialpost.com

    EU says it has reached goal of vaccinating 70% of adults

    BRUSSELS — The European Commission said on Tuesday that 70% of the European Union’s adult population had been fully vaccinated against COVID-19, hitting a…

  • European Airlines Weaker As EU, U.S. Try to Limit Transatlantic Travel By Investing.com
    investing.com

    European Airlines Weaker As EU, U.S. Try to Limit Transatlantic Travel By Investing.com

    European Airlines Weaker As EU, U.S. Try to Limit Transatlantic Travel

  • What Happens When The COVID-19 Vaccines Enter The Body – A Road Map For Kids And Grown-Ups
    businessworld.in

    What Happens When The COVID-19 Vaccines Enter The Body – A Road Map For Kids And Grown-Ups

    The Pfizer-BioNTech, Moderna and Johnson & Johnson vaccines all work similarly by giving the body’s cells the instructions to make the spike protein. , , COVID-19 Pandemic, SARS-CoV-2 virus, united states

  • High Virus Count in the Lungs Drives Covid-19 Deaths
    markets.businessinsider.com

    High Virus Count in the Lungs Drives Covid-19 Deaths

    NEW YORK, Aug. 31, 2021 /PRNewswire/ — A buildup of coronavirus in the lungs is likely behind the steep mortality rates seen in the pandemic, a n…

  • High Virus Count In The Lungs Drives Covid-19 Deaths
    thestreet.com

    High Virus Count In The Lungs Drives Covid-19 Deaths

    NEW YORK, Aug. 31, 2021 /PRNewswire/ — A buildup of coronavirus in the lungs is likely behind the steep mortality rates seen in the pandemic, a new study

  • What happens when the Covid-19 vaccines enter the body – a road map for kids and grown-ups
    thehindubusinessline.com

    What happens when the Covid-19 vaccines enter the body – a road map for kids and grown-ups

    Vaccines teach your body how to gear up to fight an infection, without your body having to deal with the infection itself

  • 60% of Those Older Than 50 Who Die From CoviD Are Double Vaxxed
    lewrockwell.com

    60% of Those Older Than 50 Who Die From CoviD Are Double Vaxxed

    The oft-repeated refrain right now is that we’re in a “pandemic of the unvaccinated,” meaning those who have not received the COVID jab make up the bulk of those hospitalized and dying from the Delta variant. For example, August 20, 2021, England’s chief medical officer professor Chris Whitty tweeted:1,2 “Four weeks working on a COVID ward makes stark the reality that the majority of our hospitalized COVID patients are unvaccinated and regret delaying. Some are very sick including young adults. Please don’t delay your vaccine.” Curiously, if you take the time to actually look at the data, you’ll find that … Continue reading →

  • Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know
    zacks.com

    Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know

    Johnson & Johnson (JNJ) closed at $173.66 in the latest trading session, marking a +0.42% move from the prior day.

  • Manitoba government opens up COVID-19 vaccination card to more people
    theglobeandmail.com

    Manitoba government opens up COVID-19 vaccination card to more people

    Public health officials say vaccine appointments have increased since the measure was announced last week

  • Hedge Funds' 25 Top Blue-Chip Stocks to Buy Now
    kiplinger.com

    Hedge Funds' 25 Top Blue-Chip Stocks to Buy Now

    Hedge funds historically have loaded up on blue-chip stocks, and that's still true today. Here, we examine the smart money's favorite stock picks and what makes them so attractive.

  • UAE resumes visa issuance
    manilatimes.net

  • +++Coronavirus-Update+++ - Coronavirus: BAG meldet 6198 neue Ansteckungen seit Freitag - Bündner Regierung denkt über Zertifikats-Pflicht...
    cash.ch

    +++Coronavirus-Update+++ – Coronavirus: BAG meldet 6198 neue Ansteckungen seit Freitag – Bündner Regierung denkt über Zertifikats-Pflicht im ÖV nach – EU streicht USA und Israel von Liste sicherer Sta

    Erfahren Sie hier alle aktuellen Entwicklungen zur Coronavirus-Krise, zusammengetragen von der Redaktion von cash.ch.

  • Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now
    zacks.com

    Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

    Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.

  • Judge rules Chicago mother can’t see her son until she gets a COVID-19 vaccine
    marketwatch.com

    Judge rules Chicago mother can’t see her son until she gets a COVID-19 vaccine

    The divorced mom had her child visitation rights revoked over her vaccination status, and is appealing the decision.

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Johnson & Johnson Aktie

Das Unternehmen Johnson & Johnson aus USA beschäftigt 141.700 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Drogerie & Kosmetik, Biotechnologie, Pharma tätig.

Johnson & Johnson ist in ungefähr 18 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter UBS ETF (IE) Factor  MSCI USA  Quality  UCITS  ETF (hedged to CHF) A-acc gewichtet Johnson & Johnson mit 4,34% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Johnson & Johnson Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Johnson & Johnson am höchsten gewichtet ist Insgesamt in 18 ETFs enthalten

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect